ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1768

Cardiac Involvement in Granulomatosis with Polyangiitis: A Magnetic Resonance Imaging Study of 31 Consecutive Patients

Grégory Pugnet1,2, Xavier Puéchal1, Benjamin Terrier1, Hervé Gouya3, Andre Kahan4, Paul Legmann3, Loïc Guillevin1 and Olivier Vignaux5, 1National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, Paris, France, 2Toulouse University Hospital, Internal Medicine Department, Toulouse, France, 3AP-HP Cochin Hospital, Department of Radiology B, Paris, France, 4Paris Descartes University, Rheumatology A department, Cochin Hospital, Paris, France, 5Radiology, Cochin University Hospital, Paris, France

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: MRI and Wegener's granulomatosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose Cardiac manifestations in granulomatosis with polyangiitis (GPA) patients are usually considered to be rare but may be life-threatening.  However specific cardiac involvement in GPA is probably underestimated during life because many of these cardiac disturbances are subclinical. Contrast-enhanced cardiac magnetic resonance imaging (CMRI) may be a sensitive tool to detect and analyze cardiac involvement in ANCA associated vasculitis. The objective of our study was to  assess the prevalence and patterns of cardiac abnormalities detected by cardiac magnetic resonance imaging in patients with GPA.

Methods

Thirty-one consecutive patients with either new or relapsing GPA underwent CMRI to determine morphological, functional, perfusion at rest and delayed enhancement abnormalities.

Results

At least one abnormality on CMRI was observed in 19/31 patients (61.3%). Four patients (14.8%) had an impaired left ventricle (LV) ejection fraction with evidence of clinically cardiac failure in two of them. LV kinetic abnormalities were found in 11 patients (36.7%). Myocardial delayed contrast enhancement (DCE) was detected in 9/31 patients (29%), 6 of whom with cardiac manifestations. DCE was mainly nodular (n = 7/9). Myocardial early contrast enhancement was detected in 5 of the 31 patients (16.1%) and was always associated with DCE in the same territory. CMRI detected pericarditis in 7 patients (22.6%). GPA of less than 18 months duration as compared with GPA of longer duration had greater LV ejection fraction (P=0.008) and less CMRI abnormalities (P=0.04), DCE (P=0.19) or LV hypokinesia (P=0.04). Patients who presented with new-onset GPA had less CMRI abnormalities than patients who experienced a relapse (P= 0.02).

Conclusion CMRI is an accurate technique for diagnosing heart involvement in GPA and for analyzing precisely its mechanisms including inflammatory, microvascular and fibrotic components. This unique noninvasive information may have important clinical implications in early and accurate assessment of cardiac lesions in GPA patients but also to detect cumulative non reversible damage. Moreover, it may have prognostic implications.


Disclosure:

G. Pugnet,
None;

X. Puéchal,
None;

B. Terrier,
None;

H. Gouya,
None;

A. Kahan,
None;

P. Legmann,
None;

L. Guillevin,
None;

O. Vignaux,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cardiac-involvement-in-granulomatosis-with-polyangiitis-a-magnetic-resonance-imaging-study-of-31-consecutive-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology